These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 10985361

  • 1. The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage.
    Elmaagacli AH, Beelen DW, Opalka B, Seeber S, Schaefer UW.
    Ann Hematol; 2000 Aug; 79(8):424-31. PubMed ID: 10985361
    [Abstract] [Full Text] [Related]

  • 2. Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using a 'real time' quantitative RT-PCR assay.
    Preudhomme C, Révillion F, Merlat A, Hornez L, Roumier C, Duflos-Grardel N, Jouet JP, Cosson A, Peyrat JP, Fenaux P.
    Leukemia; 1999 Jun; 13(6):957-64. PubMed ID: 10360386
    [Abstract] [Full Text] [Related]

  • 3. Comparison of genomic DNA and cDNA for detection of residual disease after treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation.
    Zhang JG, Lin F, Chase A, Goldman JM, Cross NC.
    Blood; 1996 Mar 15; 87(6):2588-93. PubMed ID: 8630427
    [Abstract] [Full Text] [Related]

  • 4. Estimating the relapse stage in chronic myeloid leukaemia patients after allogeneic stem cell transplantation by the amount of BCR-ABL fusion transcripts detected using a new real-time polymerase chain reaction method.
    Elmaagacli AH, Freist A, Hahn M, Opalka B, Seeber S, Schaefer UW, Beelen DW.
    Br J Haematol; 2001 Jun 15; 113(4):1072-5. PubMed ID: 11442504
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia.
    Roth MS, Antin JH, Ash R, Terry VH, Gotlieb M, Silver SM, Ginsburg D.
    Blood; 1992 Jan 01; 79(1):276-82. PubMed ID: 1728316
    [Abstract] [Full Text] [Related]

  • 6. Molecular monitoring of BCR-ABL transcripts after allogeneic stem cell transplantation for chronic myeloid leukemia.
    Arpinati M, Tolomelli G, Bochicchio MT, Castagnetti F, Amabile M, Bandini G, Bonifazi F, Stanzani M, Rosti G, Martinelli G, Baccarani M.
    Biol Blood Marrow Transplant; 2013 May 01; 19(5):735-40. PubMed ID: 23333776
    [Abstract] [Full Text] [Related]

  • 7. Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantation.
    Eder M, Battmer K, Kafert S, Stucki A, Ganser A, Hertenstein B.
    Leukemia; 1999 Sep 01; 13(9):1383-9. PubMed ID: 10482989
    [Abstract] [Full Text] [Related]

  • 8. Quantitative real-time reverse-transcription polymerase chain reaction for diagnosis of BCR-ABL positive leukemias and molecular monitoring following allogeneic stem cell transplantation.
    Neumann F, Herold C, Hildebrandt B, Kobbe G, Aivado M, Rong A, Free M, Rössig R, Fenk R, Schneider P, Gattermann N, Royer-Pokora B, Haas R, Kronenwett R.
    Eur J Haematol; 2003 Jan 01; 70(1):1-10. PubMed ID: 12631253
    [Abstract] [Full Text] [Related]

  • 9. Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha.
    Merx K, Müller MC, Kreil S, Lahaye T, Paschka P, Schoch C, Weisser A, Kuhn C, Berger U, Gschaidmeier H, Hehlmann R, Hochhaus A.
    Leukemia; 2002 Sep 01; 16(9):1579-83. PubMed ID: 12200666
    [Abstract] [Full Text] [Related]

  • 10. [Monitoring bcr-abl mRNA levels by real-time quantitative RT-PCR in chronic myeloid leukemia patients after hematopoietic stem cell transplantation].
    Qin YZ, Li JL, Zhu HH, Ruan GR, Li LD, Zhang Y, Xu LP, Liu DH, Liu YR, Huang XJ, Chen SS, Lu DP.
    Zhonghua Xue Ye Xue Za Zhi; 2006 Aug 01; 27(8):511-4. PubMed ID: 17172121
    [Abstract] [Full Text] [Related]

  • 11. Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients.
    Guo JQ, Lin H, Kantarjian H, Talpaz M, Champlin R, Andreeff M, Glassman A, Arlinghaus RB.
    Leukemia; 2002 Dec 01; 16(12):2447-53. PubMed ID: 12454751
    [Abstract] [Full Text] [Related]

  • 12. Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction.
    Sawyers CL, Timson L, Kawasaki ES, Clark SS, Witte ON, Champlin R.
    Proc Natl Acad Sci U S A; 1990 Jan 01; 87(2):563-7. PubMed ID: 2405384
    [Abstract] [Full Text] [Related]

  • 13. Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission.
    Paschka P, Müller MC, Merx K, Kreil S, Schoch C, Lahaye T, Weisser A, Petzold A, König H, Berger U, Gschaidmeier H, Hehlmann R, Hochhaus A.
    Leukemia; 2003 Sep 01; 17(9):1687-94. PubMed ID: 12970765
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning.
    Lange T, Deininger M, Brand R, Hegenbart U, Al-Ali H, Krahl R, Poenisch W, Uharek L, Leiblein S, Gentilini C, Petersdorf E, Storb RF, Niederwieser D.
    Leukemia; 2004 Sep 01; 18(9):1468-75. PubMed ID: 15241437
    [Abstract] [Full Text] [Related]

  • 16. Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation.
    Lin F, van Rhee F, Goldman JM, Cross NC.
    Blood; 1996 May 15; 87(10):4473-8. PubMed ID: 8639810
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210(BCR-ABL) and p190(BCR-ABL) after allogeneic bone marrow transplantation for chronic myeloid leukemia: increasing mixed myeloid chimerism and p190(BCR-ABL) detection precede cytogenetic relapse.
    Serrano J, Roman J, Sanchez J, Jimenez A, Castillejo JA, Herrera C, Gonzalez MG, Reina L, Rodriguez MC, Alvarez MA, Maldonado J, Torres A.
    Blood; 2000 Apr 15; 95(8):2659-65. PubMed ID: 10753848
    [Abstract] [Full Text] [Related]

  • 19. Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR.
    Emig M, Saussele S, Wittor H, Weisser A, Reiter A, Willer A, Berger U, Hehlmann R, Cross NC, Hochhaus A.
    Leukemia; 1999 Nov 15; 13(11):1825-32. PubMed ID: 10557058
    [Abstract] [Full Text] [Related]

  • 20. Rapid quantitative detection of BCR-ABL transcripts in chronic myeloid leukemia patients by real-time reverse transcriptase polymerase-chain reaction using fluorescently labeled probes.
    Bolufer P, Sanz GF, Barragán E, Sanz MA, Cervera J, Lerma E, Senent L, Moreno I, Planelles MD.
    Haematologica; 2000 Dec 15; 85(12):1248-54. PubMed ID: 11114130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.